Literature DB >> 12225382

The role of dendritic cell subsets in selection between tolerance and immunity.

Gabrielle T Belz1, William R Heath, Francis R Carbone.   

Abstract

Dendritic cells (DC) are considered nature's adjuvants. They are potent stimulators of naive T cells and key inducers of primary immune responses. In recent times it has become clear that they can also play a central role in the development of T cell tolerance. Further complicating our understanding of DC function is the realization that DC can no longer be viewed as a homogeneous cell type. Rather, they exist as a complex mixture of strikingly different cell populations. The mechanisms that drive the conflicting immunological outcomes of tolerance and immunity have been the subject of intense scrutiny in recent years, most recently in terms of how the various DC subsets are involved in these events. Here we review recent experiments that provide insights into how DC subsets control the outcome of T cell activation and in so doing select between immunity and tolerance induction.

Mesh:

Substances:

Year:  2002        PMID: 12225382     DOI: 10.1046/j.1440-1711.2002.01116.x

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  20 in total

1.  The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture.

Authors:  Petra Schnorrer; Georg M N Behrens; Nicholas S Wilson; Joanne L Pooley; Christopher M Smith; Dima El-Sukkari; Gayle Davey; Fiona Kupresanin; Ming Li; Eugene Maraskovsky; Gabrielle T Belz; Francis R Carbone; Ken Shortman; William R Heath; Jose A Villadangos
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-28       Impact factor: 11.205

2.  Priming CD8+ T cells with dendritic cells matured using TLR4 and TLR7/8 ligands together enhances generation of CD8+ T cells retaining CD28.

Authors:  Jeffrey S Pufnock; Melinda Cigal; Lisa S Rolczynski; Erica Andersen-Nissen; Mathias Wolfl; M Juliana McElrath; Philip D Greenberg
Journal:  Blood       Date:  2011-04-14       Impact factor: 22.113

3.  PD-L1 blockade improves immune dysfunction of spleen dendritic cells and T-cells in zymosan-induced multiple organs dysfunction syndromes.

Authors:  Qian Liu; Yi Lv; Min Zhao; Yiduo Jin; Jiangyang Lu
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

4.  Distinct dendritic cell subsets dictate the fate decision between effector and memory CD8(+) T cell differentiation by a CD24-dependent mechanism.

Authors:  Taeg S Kim; Stacey A Gorski; Steven Hahn; Kenneth M Murphy; Thomas J Braciale
Journal:  Immunity       Date:  2014-03-13       Impact factor: 31.745

5.  Immune tolerance of mice allogenic tooth transplantation induced by immature dendritic cells.

Authors:  Wenying Li; Feng Deng; Yu Wang; Ce Ma; Yurong Wang
Journal:  Int J Clin Exp Med       Date:  2015-04-15

Review 6.  The Biology and Underlying Mechanisms of Cross-Presentation of Exogenous Antigens on MHC-I Molecules.

Authors:  Freidrich M Cruz; Jeff D Colbert; Elena Merino; Barry A Kriegsman; Kenneth L Rock
Journal:  Annu Rev Immunol       Date:  2017-01-11       Impact factor: 28.527

7.  Dendritic cells induce immunity and long-lasting protection against blood-stage malaria despite an in vitro parasite-induced maturation defect.

Authors:  Dodie S Pouniotis; Owen Proudfoot; Violeta Bogdanoska; Vasso Apostolopoulos; Theodora Fifis; Magdalena Plebanski
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

8.  CD40 Ligand-activated, antigen-specific B cells are comparable to mature dendritic cells in presenting protein antigens and major histocompatibility complex class I- and class II-binding peptides.

Authors:  Tahamtan Ahmadi; Amanda Flies; Yvonne Efebera; David H Sherr
Journal:  Immunology       Date:  2007-12-07       Impact factor: 7.397

9.  Rabbit polyclonal mouse antithymocyte globulin administration alters dendritic cell profile and function in NOD mice to suppress diabetogenic responses.

Authors:  Yanfei Huang; Matthew Parker; Changqing Xia; Ruihua Peng; Clive Wasserfall; Tracy Clarke; Lizhen Wu; Tayseer Chowdhry; Martha Campbell-Thompson; John Williams; Michael Clare-Salzler; Mark A Atkinson; Karl L Womer
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

10.  A microsphere-based vaccine prevents and reverses new-onset autoimmune diabetes.

Authors:  Brett Phillips; Karen Nylander; Jo Harnaha; Jennifer Machen; Robert Lakomy; Alexis Styche; Kimberly Gillis; Larry Brown; Debra Lafreniere; Michael Gallo; Janet Knox; Kenneth Hogeland; Massimo Trucco; Nick Giannoukakis
Journal:  Diabetes       Date:  2008-03-03       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.